C-H9L9Lionheart Health, Inc.
bioelectrics, biologics, regenerative medtech
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-H9L9
C-H9L9C-H9L9bioelectrics, biologics, regenerative medtech
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Lionheart Health, Inc. bioelectrics, biologics, regenerative medtech
Leonhardt Ventures describes itself as a venture creation lab, product invention development laboratory, venture fund, angels network and feeder of innovations to Cal-Xelerator and Cal-X Stars. Its platform focuses on bioelectric signaling sequence-controlled expression of organ regeneration proteins, refillable micro-infusion pumps, and multicomponent stem-cell plus support-factor compositions. The site states its products are in early-stage development and investigational use only, not available for sale.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Lionheart Health, Inc. — Translational · Bottom quartile. Derived deterministically from 34 extracted project(s). Most-advanced status: phase 2. Band: translational. Modifiers: +5 depth (2 programs at…
Source: Deterministic